Fuso Pharmaceutical Industries,Ltd.JP:4538Cash flow

Market cap
¥22.4B
P/E ratio
8.8x
2015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Depreciation & amortization1,9141,5132,0041,9211,9672,3812,4102,5592,4862,2632,354
Cash from operations 1,9432,1171,8761,4202,0515,7263,2303,4982,853627-3,305
Capital expenditures-2,538-5,312-1,838-961-2,296-2,492-1,182-1,408-1,546-3,245-2,122
Cash from investing -2,890-5,336-786-984-2,369-1,485-978-1,553-1,373-3,536-3,168
Payments for dividends -722-721-717-706-700-613-525-525-525-645-638
Repurchases of common stock-10-7-282-427-6-2-4-2-3-652-4
Proceeds from issuance of term debt, net3,1506,7003,5004,6004,9003,2502,4002,8903,5364,9001,300
Repayments of term debt-3,193-3,214-3,465-3,456-3,871-4,370-4,314-4,032-3,819-3,587-8,382
Cash from financing -9552,326-1,14569-313-1,799-2,446-1,671-813147,618